StockData
CTT Pharmaceutical Holdings, Inc. logo

CTT Pharmaceutical Holdings, Inc. (CTTH) stock

CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)

Close on Oct 16, 2026Market cap $1.26MP/E –Yield –

CTT Pharmaceutical net income

Net income is the profit left for shareholders after every expense, interest and tax.

CTT Pharmaceutical's net income for the twelve months ending Sep 30, 2015 was -$1.67M. For fiscal 2014 it was -$672.16K. The highest annual figure on record is $3.74M in fiscal 2011.

Annual net income

PeriodPeriod endValueChange
FY2014Dec 31, 2014-$672.16K–
FY2013Dec 31, 2013-$18.91K–
FY2012Dec 31, 2012-$1.00M-126.8%
FY2011Dec 31, 2011$3.74M–
FY2010Dec 31, 2010-$1.10M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2015Sep 30, 2015-$341.93K–
Q2 FY2015Jun 30, 2015-$362.66K–
Q1 FY2015Mar 31, 2015-$337.05K–
Q4 FY2014Dec 31, 2014-$628.52K–
Q3 FY2014Sep 30, 2014-$43.20K–
Q2 FY2014Jun 30, 2014-$920–
Q1 FY2014Mar 31, 2014-$1.67K–
Q4 FY2013Dec 31, 2013-$7.49K–
Q3 FY2013Sep 30, 2013-$8.47K–
Q2 FY2013Jun 30, 2013-$63.71K–
Q1 FY2013Mar 31, 2013-$40.45K–
Q4 FY2012Dec 31, 2012-$176.23K–
Q3 FY2012Sep 30, 2012-$108.99K–
Q2 FY2012Jun 30, 2012-$35.59K–
Q1 FY2012Mar 31, 2012-$582.38K-110.2%
Q4 FY2011Dec 31, 2011-$429.86K–
Q3 FY2011Sep 30, 2011-$442.12K–
Q2 FY2011Jun 30, 2011-$1.08M–
Q1 FY2011Mar 31, 2011$5.69M–
Q4 FY2010Dec 31, 2010-$514.35K–
Q3 FY2010Sep 30, 2010-$442.27K–
Q2 FY2010Jun 30, 2010-$1.38K–

More CTT Pharmaceutical figures

See a number that looks wrong?